Les Newsletters de Stop-Tabac.ch

Webmasters - Proposez nos news sur votre site

Rechercher dans les anciennes newsletter:

20 mai 2008

Menu: - Forum - Témoignages - Coach - Testez-vous - Médicaments - Maladies - Brochures

 


Nouvelles sur le tabagisme de Stop-tabac.ch
Préparées par Jean-François Etter
Le 20 Mai 2008

 


- Interdiction de fumer: les livraisons de tabac ont chuté de 10% en avril
- Journées de formation "tabac" offertes par le CIPRET-Vaud
- A Clinical Blueprint to Accelerate the Elimination of Tobacco Use


Interdiction de fumer: les livraisons de tabac ont chuté de 10% en avril

PARIS - Les livraisons de tabac aux buralistes français ont continué de chuter en avril, de 10,2% par rapport au même mois en 2007, touchés par l'interdiction de fumer dans lieux publics en France, selon un communiqué de la Fédération des industries du tabac mercredi.

Sur la période de janvier à avril 2008, les ventes journalières de cigarettes aux buralistes ont chuté de 5,2% par rapport à la même période de l'année dernière.

Il y a un mois, les ventes de tabac avaient déjà dévissé de 10% par rapport à mars 2007 et de 5% sur les trois premiers mois de l'année. En janvier, les commandes de tabac des buralistes avaient baissé de 6,3% mais avaient ensuite augmenté de 2,3% en février.
(AFP / 0! 7 mai 2008 )


Journées de formation "tabac" offertes par le CIPRET-Vaud

Les 10 et 17 juin 2008.
Ces cours sont destinés aux professionnels en contact avec des enfants, adolescents, parents, personnes souhaitant arrêter de fumer, etc... Ils sont gratuits pour tous les relais du CIPRET-Vaud (écoles, institutions, entreprises, Espaces Prévention, etc.)

1. Cours de base et matériel pédagogique
Mardi 10 juin 2008 de 8h30 à 16h00
- histoire, culture et fabrication
- les enjeux de santé publique, les produits toxiques, le rôle des cigarettiers
- les outils pédagogiques (livres, sites internet, jeux, vidéos, expositions, etc.).

2. Fumée passive et désaccoutumance
Mardi 17 juin 2008 de 8h30 à 16h00
- fumée passive et mise en place d'une politique de protection contre la fumée passive dans une institution ou! une entreprises
- désaccoutumance (stades d'arrêt, conseil minimal, substituts, gestion du stress, etc.)

Si ces cours vous intéressent, merci de vous inscrire à l'adresse suivante
: Cette adresse e-mail est protégée contre les robots spammeurs. Vous devez activer le JavaScript pour la visualiser.


A Clinical Blueprint to Accelerate the Elimination of Tobacco Use

JAMA. 2008;299(17):2083-2085.
Michael C. Fiore, MD, MPH; Carlos Roberto Jaén, MD, PhD

On May 7, 2008, the US Public Health Service (PHS) released the Clinical Practice Guideline Treating Tobacco Use and Dependence: 2008 Update.1 This guideline describes how clinicians and health care systems can significantly reduce tobacco use prevalence by delivering evidence-based treatments to their patients who smoke.

The story of tobacco control efforts over the last half-century is one of remarkable progress and promise. In 1965, current smokers outnumbered former smokers 3 to 1. During the past 40 years, the rate of quitting has so outstripped the rate of initiation that, today, there are more former smokers than current smokers.2 Since tobacco use rates peaked in the 1960s, smoking prevalence among adults has decreased by half, to about 20% today.2 Moreover, 40 years ago s! moking was viewed as a habit rather than as a chronic disease, and smokers had no access to scientifically validated treatments.

Today numerous effective treatments exist and progress in the war against tobacco is accelerating. For instance, remarkable advances have been made in the scant dozen years since the publication of the first guideline. In 1997, only 25% of managed health care plans covered any tobacco dependence treatment; this figure approached 90% by 2003.3 Numerous states added Medicaid coverage for tobacco dependence treatment since the publication of the first guideline so that by 2005, 75% offered coverage for at least 1 guideline-recommended treatment,4 although this increased coverage often includes barriers to use. In 2002, the Joint Commission (formerly the Joint Commission on Accreditation of Healthcare Organizations), which accredits some 15 000 hospitals and health care programs, instituted an accreditation requirement for the delivery of ev! idence-based tobacco dependence interventions for patients with diagno ses of acute myocardial infarction, congestive heart failure, or pneumonia. Medicare, the Veteran's Health Administration, and the US military now provide coverage for tobacco dependence treatment, and every state has a telephone tobacco quitline. Such policies and systems changes are paying off in terms of increased rates of tobacco intervention and cessation.5-7

While this progress has been impressive, tobacco use remains an enormous health threat, as 45 million US adults continue to smoke.8 Given that more than 70% of these smokers visit a health care setting each year, clinicians are ideally situated to increase the rate of tobacco cessation among these smokers and reduce their risk of tobacco-caused disease. The promise of the clinical visit is enhanced because, as shown in the 2008 guideline update, numerous effective tobacco dependence treatments existtreatments that significantly increase the likelihood of tobacco users both making quit attempts and success! fully quitting.

A major obstacle to greater reductions in tobacco use prevalence is that clinicians do not consistently provide these effective smoking cessation treatments.9 This produces a rare confluence of circumstances: (1) a highly significant health threat; (2) a disinclination among clinicians to intervene consistently; and (3) the presence of clinically effective, and cost-effective, interventions. Indeed, it is difficult to identify any other condition that presents such a mix of lethality, prevalence, and neglect, despite effective and readily available interventions.10 The 2008 guideline update directly addresses these circumstances by identifying effective interventions as well as treatment delivery systems that have the potential to increase tobacco users' exposure to effective treatment.1

This 2008 guideline update builds substantially on evidence and conclusions published in the 1996 and 2000 guidelines.11-12 The update contains findings ! and recommendations that are based on a systematic review of almost 90 00 publications, more than 50 meta-analyses, and expert summaries of relevant literature. The guideline provides a blueprint for clinicians and health care systems, describing how smokers can access effective treatments, how clinicians can provide such treatments quickly and effectively, and how health care systems can support both smokers and clinicians in smoking cessation efforts...

http://jama.ama-assn.org/cgi/content/full/299/17/2083

US DHHS Guidelines:

Treating Tobacco Use and Dependence: 2008 UpdateClinical Practice Guideline
http://www.surgeongeneral.gov/tobacco/treating_tobacco_use08.pdf

Also:
Helping Smokers QuitA Guide for Clinicians
http://www.ahrq.gov/clinic/tobacco/clinhlpsmksqt.pdf
Help for! Smokers and Other Tobacco Users
http://www.ahrq.gov/consumer/tobacco/lowlit.pdf



Retour à la liste des newsletters